Recently, Elbaset et al. reported that pitavastatin reduces thioacetamide (TAA)-induced renal injury [58] and liver fibrosis [59] in rats by suppressing PI3K/AKT/mTOR signaling. Here, MTOR is linked to Hepatic fibrosis.